• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Sep30
Distribution Plan(EST)

Cash dividend 0.3101 USD

Sep23
Distribution Plan(EST)

Cash dividend 0.3101 USD

Distribution Plan(EST)

Cash dividend 0.3101 USD

View More

Event Tracking

Dec15
Johnson & Johnson's Prostate Cancer Therapy Akeega Receives FDA Approval
09:36
U.S. Trust Increases Holdings in AbbVie Inc.
08:02
American Trust Increases Stake in Eli Lilly and Company by 147.1%
08:00
Analysis article discusses how Eli Lilly became a trillion-dollar pharmaceutical giant with its 'miracle weight-loss drugs'
07:02
Eli Lilly's triple-agonist weight-loss drug Retatrutide shows outstanding efficacy in Phase 3 clinical data, but side effects require attention
00:00
Dec14
Eli Lilly's next-generation weight loss drug, Retatrutide, succeeds in Phase 3 trial
23:30